XLVvsBBHETF Comparison
VS
State Street Health Care Select Sector SPDR ETF (XLV) and VanEck Biotech ETF (BBH) belong to the same industry segment: US Health Care. XLV's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, BBH's top sector exposures are Healthcare. XLV is less expensive with a Total Expense Ratio (TER) of 0.08%, versus 0.35% for BBH. XLV is up 17.24% year-to-date (YTD) with +$1.03B in YTD flows. BBH performs better with 30.28% YTD performance, and +$14M in YTD flows. Run a side-by-side ETF comparison of XLV and BBH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XLV vs BBH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/23/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLV BBH | +6.22%+2.59% | +11.46%+20.83% | +17.24%+30.28% | +24.79%+39.64% | +48.03%+68.09% | +47.51%+26.27% |
| Flows | XLV BBH | +$1.21B+$7M | +$92M+$22M | +$1.03B+$14M | +$1.68B+$16M | -$3.62B-$134M | +$4.34B-$134M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLV BBH | +17.60%+28.43% | +16.35%+22.41% | +14.97%+20.57% | +15.25%+21.85% |
| Max drawdown | XLV BBH | -5.81%-6.32% | -10.51%-10.54% | -17.05%-22.78% | -17.05%-34.47% |
| Max drawdown duration | XLV BBH | 56d36d | 116d150d | 444d440d | 444d1525d |
Trading data
XLV | BBH | |
Last sale 10/23/2026 at 1:30 PM | $179.28 | $246.57 |
| Previous close 10/22/2026 | $181.30 | $248.41 |
| Consolidated volume 10/22/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XLV | BBH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Main metrics
Last update 10/23/2026 at 1:30 PM
Live
Closed
XLV | BBH | |
|---|---|---|
| Last price | $179.28 | $246.57 |
| 1D performance | -1.11% | -0.74% |
| AuM | $46.98 B | $501.96 M |
| E/R | 0.08% | 0.35% |
Characteristics
XLV | BBH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | State Street Investment Management | VanEck |
| Benchmark | S&P Health Care Select Sector Index | MVIS US Listed Biotech 25 Index |
| N° of holdings | 59 | 24 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 1998 | December 20, 2011 |
| ESG | No | No |
Advertisement
Exposure
Countries
XLV
USA
97.52%
Other
2.48%
BBH
USA
87.73%
Other
12.27%
Sectors
XLV
Healthcare
97.84%
Other
2.16%
BBH
Healthcare
100%
Advertisement
Diversification
XLV
Total weight of top 15 holdings out of 15
71.32%
BBH
Total weight of top 15 holdings out of 15
86.35%
Top 15 holdings
Data as of August 31, 2026
XLV
Eli Lilly & Co.
14.88%
Johnson & Johnson
10.41%
AbbVie, Inc.
7.37%
Merck & Co., Inc.
5.93%
UnitedHealth Group, Inc.
5.75%
Amgen, Inc.
3.77%
Thermo Fisher Scientific, Inc.
3.73%
Abbott Laboratories
3.13%
Gilead Sciences, Inc.
2.95%
Pfizer Inc.
2.64%
Vertex Pharmaceuticals, Inc.
2.25%
Bristol Myers Squibb Co.
2.22%
Danaher Corp.
2.19%
Intuitive Surgical, Inc.
2.17%
CVS Health Corp.
1.95%
BBH
Amgen, Inc.
15.65%
Gilead Sciences, Inc.
12.68%
Vertex Pharmaceuticals, Inc.
8.54%
Regeneron Pharmaceuticals, Inc.
6.82%
Moderna, Inc.
5.70%
Natera, Inc.
5.09%
Revolution Medicines, Inc.
5.04%
IQVIA Holdings, Inc.
5.01%
argenx SE
4.72%
Illumina, Inc.
3.35%
Biogen, Inc.
3.15%
BeOne Medicines Ltd.
3.12%
Alnylam Pharmaceuticals, Inc.
2.60%
Insmed, Inc.
2.55%
Incyte Corp.
2.35%
Frequently asked questions about XLV and BBH
How have the XLV and BBH ETFs performed in 2026?
As of October 23, 2026, XLV is up 17.24% year-to-date (YTD), while BBH has returned 30.28%. That puts BBH better performer ahead so far this year.
Which ETF is attracting more investor money: XLV or BBH?
Year-to-date, the XLV ETF saw +$1.03B in flows, compared to +$14M for BBH.
Which ETF is more volatile: XLV or BBH?
Over the past year, XLV had a volatility of 16.35%, while BBH experienced 22.41%.
Which ETF is bigger: XLV or BBH?
As of October 23, 2026, XLV holds $46.98 B in assets under management (AUM), while BBH manages $501.96 M.
What sectors do the XLV and BBH ETFs invest in?
XLV leans toward sectors like Healthcare. Meanwhile, BBH focuses on Healthcare.
What are the top holdings of the XLV ETF and BBH ETF?
XLV top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. BBH holds in its top three: Amgen, Inc., Gilead Sciences, Inc. and Vertex Pharmaceuticals, Inc..
Which ETF is more diversified: XLV or BBH?
XLV holds 59 securities with 71.32% of its assets in the top 15. BBH has 24 securities and a top 15 weight of 86.35%.
Advertisement
Latest news about XLV & BBH
ETF Model Portfolios: The Cockroach Portfolio
March 20, 2026
XLV
ETF Central's Guide to Defensive Sector Investing
March 13, 2026
XLV
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
January 27, 2025
XLV
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
August 21, 2024
XLV
Advertisement
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Advertisement
